Jin Medical turns to FY26 H1 net loss of USD 0.2 million; revenue falls 9.7% to USD 8.9 million
ZJYL•FY26 first-half results
Jin Medical posted revenue of USD 8.9 million for the six months ended March 31, 2026, down 9.7% year over year.
It turned to a net loss of USD 0.2 million from net income of USD 0.01 million; basic and diluted loss per share was USD 0.01.
Gross margin widened 2.6 percentage points to 26.9% as gross profit held at USD 2.4 million.
Segment performance and balance sheet
Wheelchair revenue slipped 1.4% to USD 7.1 million on lower orders from Japan’s Nissin amid yen weakness; wheelchair components rose 9.9% to USD 1.1 million.
Other products fell 59.1% to USD 0.7 million after electric scooter sales were halted; cash was USD 9.1 million with USD 21 million in short-term investments.
